KET to focus attention on cancer with Ken Burns series March 30-April 1, live call-in program on night of April 1

Kentucky Health News

KET will show a three-night series, “Cancer: The Emperor of All Maladies,” by Ken Burns, an in-depth look at the history of cancer, patients’ stories and the “latest scientific breakthroughs that may have, at last, brought researchers within sight of developing lasting cancer cures,” the network says in a news release.

The series, which will air March 30, 31 and April 1 at 9 p.m. ET, is based on the Pulitzer Prize-winning book The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee.

KET will air companion programs to this series that will focus on Kentuckians.

Bill Goodman will host Dr. Mark Evers, director of the Markey Cancer Center at the University of Kentucky, on “One to One” March 29 at 1 p.m. ET to discuss the latest news in cancer care and research. This show will also air on KET2 March 31 at 7:30 p.m. ET.

On April 1 at 8 p.m., Renee Shaw will host a live call-in program, “Answers for Cancer,” as part of KET’s “Health Three60” series. This show will offer viewers a chance to ask questions about cancer screening, treatment and recovery resources in Kentucky.

A recording of the program will air on KETKY April 6 at 9 a.m., April 10 at 11 a.m., April 11 at 4 a.m. and April 13 at 2 a.m. (all times ET).

Viewers can submit questions to the original program via Twitter at @HealthKET, by email at, or by phone at 800-753-6237.

Panelists on the program include Donald Miller, director of the James Graham Brown Cancer Center at the University of Louisville; Patrick Williams, medical director at Norton Cancer Institute; Timothy Mullet, lung cancer specialist with UK HealthCare, who is himself a cancer survivor; and Fran Feltner, director of the UK Center for Excellence in Rural Health.

This show will also offer a pre-taped segment that spotlights cancer screening outreach efforts in Kentucky that target high risk populations.

Previous Article
Next Article

Leave a Reply

Your email address will not be published. Required fields are marked *